Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
T102749-25g | 25g | In stock | $34.90 | |
T102749-100g | 100g | In stock | $77.90 | |
T102749-250g | 250g | In stock | $175.90 | |
T102749-500g | 500g | In stock | $231.90 |
Synonyms | Triglycidyl isocyanurate|2451-62-9|1,3,5-Triglycidyl isocyanurate|1,3,5-tris(oxiran-2-ylmethyl)-1,3,5-triazinane-2,4,6-trione|Triglycidylisocyanurate|Tris(2,3-epoxypropyl) isocyanurate|Glycidyl isocyanurate|Tri(epoxypropyl)isocyanurate|Tris(2,3-epoxypropy |
---|---|
Specifications & Purity | ≥98% |
Shipped In | Normal |
Product Description | Triglycidyl isocyanurate is a reagent used in the synthesis of N-Benzyl Metaxalone , which is a muscle relaxant used to relax muscles and relieve pain. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Pubchem Sid | 488182353 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488182353 |
IUPAC Name | 1,3,5-tris(oxiran-2-ylmethyl)-1,3,5-triazinane-2,4,6-trione |
INCHI | InChI=1S/C12H15N3O6/c16-10-13(1-7-4-19-7)11(17)15(3-9-6-21-9)12(18)14(10)2-8-5-20-8/h7-9H,1-6H2 |
InChi Key | OUPZKGBUJRBPGC-UHFFFAOYSA-N |
Canonical SMILES | C1C(O1)CN2C(=O)N(C(=O)N(C2=O)CC3CO3)CC4CO4 |
Isomeric SMILES | C1C(O1)CN2C(=O)N(C(=O)N(C2=O)CC3CO3)CC4CO4 |
RTECS | XZ1994900 |
PubChem CID | 17142 |
Molecular Weight | 297.26 |
Reaxy-Rn | 765833 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
G2418318 | Certificate of Analysis | Mar 14, 2024 | T102749 |
G2418319 | Certificate of Analysis | Mar 14, 2024 | T102749 |
A2306852 | Certificate of Analysis | Aug 23, 2022 | T102749 |
A2306939 | Certificate of Analysis | Aug 23, 2022 | T102749 |
A2306943 | Certificate of Analysis | Aug 23, 2022 | T102749 |
A2306945 | Certificate of Analysis | Aug 23, 2022 | T102749 |
A2306963 | Certificate of Analysis | Aug 23, 2022 | T102749 |
A2307042 | Certificate of Analysis | Aug 23, 2022 | T102749 |
A2307062 | Certificate of Analysis | Aug 23, 2022 | T102749 |
C2406039 | Certificate of Analysis | Aug 23, 2022 | T102749 |
B2223473 | Certificate of Analysis | Nov 29, 2021 | T102749 |
B2223483 | Certificate of Analysis | Nov 29, 2021 | T102749 |
B2223490 | Certificate of Analysis | Nov 29, 2021 | T102749 |
B2223502 | Certificate of Analysis | Nov 29, 2021 | T102749 |
Solubility | insoluble in water,soluble in dimethylformamide. |
---|---|
Melt Point(°C) | 108°C |
Pictogram(s) | GHS06, GHS08, GHS05, GHS07 |
---|---|
Signal | Danger |
Hazard Statements | H301:Toxic if swallowed H331:Toxic if inhaled H373:Causes damage to organs through prolonged or repeated exposure H412:Harmful to aquatic life with long lasting effects H318:Causes serious eye damage H317:May cause an allergic skin reaction H340:May cause genetic defects |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P273:Avoid release to the environment. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P260:Do not breathe dust/fume/gas/mist/vapors/spray. P281:Use personal protective equipment as required. P271:Use only outdoors or in a well-ventilated area. P270:Do not eat, drink or smoke when using this product. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P272:Contaminated work clothing should not be allowed out of the workplace. P333+P313:IF SKIN irritation or rash occurs: Get medical advice/attention. P362+P364:Take off contaminated clothing and wash it before reuse. P330:Rinse mouth. P203:Obtain, read and follow all safety instructions before use. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P301+P316:IF SWALLOWED: Get emergency medical help immediately. P305+P354+P338:IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses if present and easy to do. Continue rinsing. P318:if exposed or concerned, get medical advice. P317:Get emergency medical help. P316:Get emergency medical help immediately. P319:Get medical help if you feel unwell. |
RTECS | XZ1994900 |
Reaxy-Rn | 765833 |
1. K Nishioka,M Ogasawara,C Asagami. (1988-11-01) Occupational contact allergy to triglycidyl isocyanurate (TGIC, Tepic).. Contact dermatitis, 19 ((5)): (379-380). [PMID:2976653] |
2. J A Neidhart,D Derocher,M R Grever,E H Kraut,L Malspeis. (1984-09-01) Phase I trial of teroxirone.. Cancer treatment reports, 68 ((9)): (1115-1119). [PMID:6478450] |
3. G Atassi,P Dumont,U Fisher,M Zeidler,M Budnowski. (1984-03-01) Preclinical evaluation of the anti tumour activity of new epoxyde derivatives.. Cancer treatment reviews, 11 Suppl A (99-110). [PMID:6733721] |
4. M M Ames,J S Kovach,J Rubin. (1984-09-01) Pharmacological characterization of teroxirone, a triepoxide antitumor agent, in rats, rabbits, and humans.. Cancer research, 44 ((9)): (4151-4156). [PMID:6744326] |
5. R Jolanki,L Kanerva,T Estlander,K Tarvainen. (1994-01-01) Concomitant sensitization to triglycidyl isocyanurate, diaminodiphenylmethane and 2-hydroxyethyl methacrylate from silk-screen printing coatings in the manufacture of circuit boards.. Contact dermatitis, 30 ((1)): (12-15). [PMID:8156756] |
6. J P McFadden,R J Rycroft. (1993-04-01) Occupational contact dermatitis from triglycidyl isocyanurate in a powder paint sprayer.. Contact dermatitis, 28 ((4)): (251-251). [PMID:8508645] |
7. W Wigger-Alberti,M Hofmann,P Elsner. (1997-06-01) Contact dermatitis caused by triglycidyl isocyanurate.. American journal of contact dermatitis : official journal of the American Contact Dermatitis Society, 8 ((2)): (106-107). [PMID:9153332] |
8. P Piirilä,T Estlander,H Keskinen,R Jolanki,A Laakkonen,P Pfäffli,O Tupasela,M Tuppurainen,H Nordman. (1997-05-01) Occupational asthma caused by triglycidyl isocyanurate (TGIC).. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 27 ((5)): (510-514). [PMID:9179424] |
9. N M Craven,M Bhushan,M H Beck. (1999-02-03) Sensitization to triglycidyl isocyanurate, epoxy resins and acrylates in a developmental chemist.. Contact dermatitis, 40 ((1)): (54-55). [PMID:9928813] |
10. U Erikstam,M Bruze,A Goossens. (2001-01-13) Degradation of triglycidyl isocyanurate as a cause of false-negative patch test reaction.. Contact dermatitis, 44 ((1)): (13-17). [PMID:11156005] |
11. E Silva,L Hernandez,B Quiñonez,L E Gonzalez,C Colasante. (2004-02-26) Selective amino acids changes in the medial and lateral preoptic area in the formalin test in rats.. Neuroscience, 124 ((2)): (395-404). [PMID:14980389] |
12. Martin Roff,David A Bagon,Helen Chambers,E Martin Dilworth,Nicholas Warren. (2004-04-03) Dermal exposure to dry powder spray paints using PXRF and the method of Dirichlet tesselations.. The Annals of occupational hygiene, 48 ((3)): (257-265). [PMID:15059802] |
13. John White. (2004-08-05) Determination of triglycidyl isocyanurate from powder coatings in occupational hygiene samples by gas chromatography with mass spectrometric detection.. The Annals of occupational hygiene, 48 ((6)): (555-563). [PMID:15292038] |
14. Sébastien Gagné,Marielle Carrier,Simon Aubin. (2015-09-26) Determination of triglycidyl isocyanurate from air samples by ultra-performance liquid chromatography coupled with coordination ion spray mass spectrometry.. Rapid communications in mass spectrometry : RCM, 29 ((10)): (913-918). [PMID:26407305] |
15. Yu Qi,Haiqing Song,Haihua Xiao,Gang Cheng,Bingran Yu,Fu-Jian Xu. (2018-09-22) Fluorinated Acid-Labile Branched Hydroxyl-Rich Nanosystems for Flexible and Robust Delivery of Plasmids.. Small (Weinheim an der Bergstrasse, Germany), 14 ((42)): (e1803061-e1803061). [PMID:30238691] |
16. E Bahsi,S Sagmak,B Dayi,O Cellik,Z Akkus. (2019-07-12) The evaluation of microleakage and fluoride release of different types of glass ionomer cements.. Nigerian journal of clinical practice, 22 ((7)): (961-970). [PMID:31293262] |
17. Kun Zhang,Yan Huang,Yin-Jing Shen,Lin-Feng Zhang,Shuang Ma,Ting-Ting Chen,Ziqiang Zheng,Shishen Zhang,Benxia Li. (2021-01-18) Imine bond transformation of a dynamic Sm(III) macrocycle-based chemosensor: The indirect approach for detecting cyanuric chloride.. Analytica chimica acta, 1144 (34-42). [PMID:33453795] |
18. C S Munro,C M Lawrence. (1992-01-01) Occupational contact dermatitis from triglycidyl isocyanurate in a powder paint factory.. Contact dermatitis, 26 ((1)): (59-59). [PMID:1534738] |
19. A Dooms-Goossens,R Bedert,M Vandaele,H Degreef. (1989-09-01) Airborne contact dermatitis due to triglycidylisocyanurate.. Contact dermatitis, 21 ((3)): (202-203). [PMID:2791551] |
20. A Hempel,N Camerman,A Camerman. (1989-03-01) Crystallographic resolution and crystal and molecular structures of stereoisomers of 1,3,5-triglycidyl-s-triazinetrione.. Journal of medicinal chemistry, 32 ((3)): (648-651). [PMID:2918513] |
21. C G Mathias. (1988-07-01) Allergic contact dermatitis from triglycidyl isocyanurate in polyester paint pigments.. Contact dermatitis, 19 ((1)): (67-68). [PMID:2972516] |
22. H Fischer,U Zeidler,M Budnowski,G Atassi,P Dumont,J Venditti,O C Yoder. (1984-01-01) Investigation of the antitumor activity of new epoxide derivatives. Part I: s-Triazinetrione derivatives.. Arzneimittel-Forschung, 34 ((5)): (543-547). [PMID:6540567] |
23. P Dombernowsky,B Lund,H H Hansen. (1983-01-01) Phase-I study of alpha-1,3,5-triglycidyl-s-triazinetrione (NSC 296934).. Cancer chemotherapy and pharmacology, 11 ((1)): (59-61). [PMID:6883626] |
24. L Meuleman,A Goossens,C Linders,F Rochette,B Nemery. (1999-08-12) Sensitization to triglycidylisocyanurate (TGIC) with cutaneous and respiratory manifestations.. Allergy, 54 ((7)): (752-756). [PMID:10442533] |
25. Sarah Allmaras. (2003-02-08) Worker exposure to 1,3,5-triglycidyl isocyanurate (TGIC) in powder paint coating operations.. Applied occupational and environmental hygiene, 18 ((3)): (151-153). [PMID:12573957] |
26. Joaquín Sastre,Jerónimo Carnes,Manuela García del Potro,Luis Manso,Erika Aguado,Mar Fernández-Nieto. (2010-08-19) Occupational asthma caused by triglycidyl isocyanurate.. International archives of occupational and environmental health, 84 ((5)): (547-549). [PMID:20717691] |
27. W Anees,V C Moore,J S Croft,A S Robertson,P S Burge. (2010-11-03) Occupational asthma caused by heated triglycidyl isocyanurate.. Occupational medicine (Oxford, England), 61 ((1)): (65-67). [PMID:21041841] |
28. Jing-Ping Wang,Kai-Han Lin,Chun-Yen Liu,Ya-Chu Yu,Pei-Tsun Wu,Chien-Chih Chiu,Chun-Li Su,Kwun-Min Chen,Kang Fang. (2013-08-21) Teroxirone inhibited growth of human non-small cell lung cancer cells by activating p53.. Toxicology and applied pharmacology, 273 ((1)): (110-120). [PMID:23954467] |
29. Beatriz Melendez-Rodriguez,Sergio Torres-Giner,Abdulaziz Aldureid,Luis Cabedo,Jose M Lagaron. (2019-07-07) Reactive Melt Mixing of Poly(3-Hydroxybutyrate)/Rice Husk Flour Composites with Purified Biosustainably Produced Poly(3-Hydroxybutyrate-co-3-Hydroxyvalerate).. Materials (Basel, Switzerland), 12 ((13)): [PMID:31277419] |